EF
ACAD icon

Empowered Funds’s Acadia Pharmaceuticals ACAD Stock Holding History

Empowered Funds’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.09M Buy
+48,982
New +$1.17M 0.01% 1379
2025
Q2 		– Sell
-11,188
Closed -$186K – 1747
2025
Q1 		$186K Buy
+11,188
New +$203K ﹤0.01% 1518

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Empowered Funds's ACAD Position: Q1 2026 in Review

Empowered Funds opened a new position in Acadia Pharmaceuticals (ACAD) in Q1 2026: 48,982 shares worth $1.09M. The stake represents 0.01% of the portfolio and ranks #1379 among its holdings. This is a return to the name: Empowered Funds previously reported a position in ACAD as recently as Q1 2025.

Empowered Funds first reported a position in ACAD in Q1 2025 and has held it in 2 quarters since. 340 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

  • Empowered Funds held 48,982 shares of Acadia Pharmaceuticals worth $1.09M as of Q1 2026.
  • Acadia Pharmaceuticals was a new Empowered Funds position in Q1 2026.
  • Acadia Pharmaceuticals made up 0.01% of Empowered Funds's portfolio in Q1 2026, its #1379 holding.
  • Empowered Funds first reported a position in Acadia Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • 340 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on Empowered Funds's 13F filing for Q1 2026, filed 15 May 2026.